[Other] Checkmate 77T: A phase III trial of neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) followed by adjuvant nivo in resectable early-stage NSCLC.

Closed

jakir_ete_ruet Post time 1 hour(s) ago | Show all posts |Read mode

Reward60points

journal：Journal of Clinical Oncology

Authors：Tina Cascone; Mariano Provencio; Boris Sepesi; Shun Lu; Nivedita Aanur; Sunney Li; Jonathan Spicer

Published date：2020-5-20

DOI：10.1200/jco.2020.38.15_suppl.tps9076

Article link：https://doi.org/10.1200/jco.2020.38.15_suppl.tps9076

Article Source：American Society of Clinical Oncology (ASCO)。

Remark：

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

jakir_ete_ruet Lv.4

Senior Member

post
reply
points
210368

[Other] Checkmate 77T: A phase III trial of neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) followed by adjuvant nivo in resectable early-stage NSCLC. Copy

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] Checkmate 77T: A phase III trial of neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) followed by adjuvant nivo in resectable early-stage NSCLC.